FDA Cracks Down on Compounded Semaglutide, Eli Lilly Slashes Zepbound Prices, and Insurance Struggles Continue

Weight-Loss Drug Wars Heat Up, PBM Reform Stalls, and Insurers Push Back

Commercial Insurance Dominated Weight Loss Prescriptions, Medicare May Target Wegovy for Price Cuts, FDA Reported Eased Drug Shortages